gastroparesis and tirzepatide with tirzepatide gastroparesis June Blog Post: T2DM Management complicated by gastroparesis GLP-1 Gastroparesis Risk: What Patients

Pregnant or breastfeeding women should avoid using semaglutide due to potential risks to the baby

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A systematic review and meta-analysis of randomised trials

Wegovy is a brand name for the medication semaglutide

The most common are digestive issues, including: Nausea (the most common) Vomiting Changes in bowel movements (constipation or diarrhea) These usually improve over time

IV therapy can rapidly restore hydration levels, improving joint lubrication and overall comfort

Our comprehensive service ensures continuous support and monitoring throughout your weight loss journey